Study · PubMed tag: Randomized Controlled Trial · 2008
Expression of concernSalvage of sildenafil failures with bremelanotide: a randomized, double-blind, placebo controlled study.
Safarinejad MR, Hosseini SY
The Journal of urology18 Jan 2008Cited by 28 (Europe PMC)
The journal published an expression of concern. The journal has doubts about the study and has not retracted it. Read the notice before you rely on it.
- Expression of concern on PubMed (PMID 36626345) (opens in a new tab)Expression of concern, Europe PMC, seen 9 Oct 2026
Summary
The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)
Text rights: Publisher copyright. Results still quote short attributed sentences.
No results listed for this study
Read the study at the source.
Version history
PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.
Versions 2 to 10Current
27 Oct 2026, 16:37 UTC
The same notice was added 9 times, first on 9 Oct 2026, 03:15 UTC. The status did not change between them.
Status changed: status, notices · status expression of concern · status notice from Retraction Watch (Crossref)
Version 1
9 Oct 2026, 03:04 UTC
First added · status expression of concern · source update from Europe PMC
Subjects
Terms as the source lists them.
Publication types
PepBank is a research reference. Talk to a doctor before you use any peptide.